Oxford BioTherapeutics Announces Receipt of a Milestone Payment as Boehringer Advances an Oncology Drug Candidate Read more
C4X Discovery and PhoreMost collaboration to accelerate Parkinson’s Disease drug discovery pipeline Read more
TLC Announces Development and License Agreement with Birdie Biopharmaceuticals for NanoX Immunotherapy Product Read more